Evidence map›Paper›PMID 30669788›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2018

[Seroepidemiological investigation of hepatitis C virus in Zhejiang Province: a hospital-based study].

P Chen, Y Zheng, H R Gao, P F Zou, Z B Zhou, Y H Ge, S B Li, Y Q Shen, L J Li

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 70% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

P ChenShu Lan(Hangzhou) Hospital, Hangzhou 310012, China;State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China.
Y ZhengCollege of Medicine, Zhejiang University, Hangzhou 310029, China.
H R GaoShu Lan(Hangzhou) Hospital, Hangzhou 310012, China.
P F ZouShu Lan(Hangzhou) Hospital, Hangzhou 310012, China.
Z B ZhouShu Lan(Hangzhou) Hospital, Hangzhou 310012, China.
Y H GeShu Lan(Hangzhou) Hospital, Hangzhou 310012, China.
S B LiZhoushan Hospital, Zhoushan 316000, China.
Y Q ShenHuzhou Central Hospital, Huzhou 313000, China.
L J LiState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China.
Zhejiang University · CNHuzhou Central Hospital · CN

Funding

The Medical & Health Technology Program of Zhejiang Province 2016KYA079The Mega-Project for National Science and Technology Development under the "13th Five-Year Plan of China" 2017ZX10105001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HepacivirusAdultAgedChinaFemaleHepatitis CHepatitis C AntibodiesHumansMaleMiddle AgedPrevalenceSeroepidemiologic StudiesYoung AdultHepatitis C AntibodiesHepatitis antibodiesHepatitis C VirusSeroepidemiologyZhejiang province

Identifiers

PMID30669788
PMCPMC12770302
OpenAlexW3025250060

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.